Journal of Clinical Research

Manohara Basoor Halasiddappa

, BDS,MICR Editor-in-Chief
Director of Clinical Operations, Clinical operations
Northwestern University School of Professional Studies Chicago, USA

Biography

Project Management for Professionals Certification Northwestern University School of Professional Studies, Chicago. Certification Clinical Research Associate- ACRP Academy of Clinical Research Professionals Post Graduate Diploma in Clinical Research- Institute of Clinical Research in India (ICRI) affiliated to Cranfield University (UK), Bangalore, India Bachelor of Dental Surgery (BDS)- Rajiv Gandhi University of Health Sciences (RGUHS), Bangalore, Karnataka, India Pharmaceutical Professional with well?rounded experience (15+ years) at start?up pharmaceutical, Global pharma, and Contract Research Organizations (CRO). Broad drug development experience in leading clinical development from First?In?Human Phase.I through Phase IV clinical trials with multiple investigational drug products in various indications.Certified peer reviewer – Elsevier and Web of Science Academy. “Thinking Critically: Interpreting Randomized Clinical Trials” certification by Stanford Medicine, USA

Research Interest

Expertise: Clinical Program Management, Vendor management, Monitoring &Site Management, Medical Writing, Data Management, Investigational Product Management, Budget, and finance management, KPI’s, Metrics, Audit preparation & Inspection readiness, Root cause analysis, CAPA, Recruitment and retention strategies, Study document management, etc.

Oncology: Gastric Cancer (GC), Colorectal (CRC), Adenoid Cystic Carcinoma (ACC),
Hepatocellular Carcinoma (HCC), Sarcomas, Ovarian Cancer and NSCLC
Chronic Infectious Disease: Hepatitis C, Hepatitis B
Immunology: Rheumatoid Arthritis, Psoriatic Arthritis
Cardiovascular: Myocardial Infarction
Dermatology: Active Psoriasis, Skin Infections & Skin and structural infections
Musculoskeletal: Low Back Pain
Neurology: Post Herpetic Neuralgia
Other: Diabetic Neuropathic Pain, Biologics, Recombinant Monoclonal Antibodies etc.